SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending following an earnings report that showed an Adjusted EBITDA miss and raised questions about earnings quality due to non-cash benefits and related-party transactions, prompting heightened community discussion alleging fraud and predicting further declines.

TOSHI

TOSHI is drawing significant community attention as a leading Base Chain memecoin, with traders actively discussing bullish technical patterns and its strong correlation with broader crypto market movements, anticipating a potential breakout as sentiment shifts towards an altcoin season.

VisionWave Holdings, Inc. engages in the forefront of revolutionizing defense capabilities by integrating advanced artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. The company was founded on March 20, 2024 and is headquartered in Wilmington, DE.

VisionWave Holdings Inc.

VisionWave Holdings, Inc.

VisionWave Holdings is a top discussion point following news of a $10 million Statement of Work for its qSpeed-Mine platform and a strategic agreement to develop an RF-based defense system, further supported by a significant institutional stake from Goldman Sachs. Community conversations are heavily focused on the company's AI defense potential, its low share float, and recent complaints by management about abnormal market activity and naked shorting, leading to significant chatter about a potential short squeeze.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending following recent European and Saudi regulatory approvals for its Anktiva cancer therapy, fueling strong community belief in its broad global potential and igniting widespread speculation of a significant short squeeze. Investors are praising the company's visionary leadership for accelerating market expansion beyond initial bladder cancer indications, positioning Anktiva as a revolutionary drug challenging those betting against a "cure for cancer."

Dogelon Mars

Dogelon Mars is trending as a metaverse land sale initiative unfolds, though community sentiment is polarized between long-term holders anticipating a reversal and those lamenting its persistent underperformance and unfulfilled "Great Burn" promises compared to other meme coins.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU is trending as its highly dedicated community relentlessly builds a "permissionless brand" with 20+ real-world initiatives, including products like KENDU SPICE, amidst challenging market conditions. Members emphasize buying dips for "generational wealth" and believe their hard work and organic growth make the project an unstoppable force poised for significant future expansion.

Bonk is a dog-themed memecoin on the Solana blockchain, launched on Christmas Day 2022 to revitalize the Solana community following the FTX collapse. Created by an anonymous team of 22 Solana developers and builders, Bonk distributed 50% of its total 100 trillion token supply via airdrop to community members including NFT collectors, developers, and artists.   The project positions itself as "the first Solana dog coin for the people, by the people," explicitly rejecting venture capital backing in favor of grassroots community ownership. What sets Bonk apart from other memecoins is its combination of fair launch mechanics, extensive ecosystem integration, and active deflationary strategy.   Built on Solana, BONK benefits from fast transaction speeds and low fees that make it practical for everyday use. Native products include LetsBonk.fun (a memecoin launchpad that briefly became Solana's market leader in 2025, surpassing Pump.fun with over 78% market share), BonkSwap (a decentralized exchange) and BonkBot (a Telegram trading bot with built-in burn mechanics).   BONK is available across 10 blockchain networks and listed on major exchanges including Binance, Coinbase, Kraken, and Robinhood. Governance is handled by BonkDAO, which holds 15% of the token supply and makes decisions through on-chain voting.   The community has organized several major burn events, most notably the December 2024 BURNmas campaign that destroyed 1.69 trillion tokens worth over $50 million. In September 2025, Nasdaq-listed Safety Shot, Inc. formed BONK Holdings LLC and acquired over 2.5% of the circulating supply (valued at $55-63 million), making BONK one of the first memecoins to attract formal corporate treasury adoption. Core contributor Nom was appointed to Safety Shot's board, and the company holds a 10% revenue share in LetsBonk.fun.  As with all memecoins, BONK is a highly speculative asset with substantial volatility. Its value is primarily driven by community sentiment, social media momentum, and meme culture rather than traditional utility.   The anonymous team, while common in the memecoin space, means investors should exercise appropriate caution. Despite these risks, Bonk has established itself as one of the most successful community-driven tokens in the Solana ecosystem, approaching 1 million unique holders and expanding from a simple memecoin into meaningful DeFi infrastructure.

BONK

BONK is seeing significant community attention as a key meme coin in the Solana ecosystem, with many actively accumulating tokens and anticipating a strong rally. Sentiment is buoyed by recent news of Bonk, Inc.'s strategic partnership and a substantial token acquisition, combined with a rapidly growing holder count approaching 1 million and ongoing token burns.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe faces intense pressure from a widespread software sector sell-off, driven by market fears that AI will disrupt its core business and make creative tools obsolete. Despite the company's strong financials, significant share buybacks, and active AI integration, the community remains sharply divided between those who view it as an undervalued opportunity and those concerned about its long-term viability.

Bakkt, Inc. is building the backbone of next-generation financial infrastructure. The company provides solutions that enable institutional participation in the digital asset economy, spanning Bitcoin, tokenization, stablecoin payments, and AI-driven finance. Bakkt was founded in 2018 and is headquartered in New York, NY.

Bakkt Inc. - Ordinary Shares - Class A

Bakkt Holdings Inc

Bakkt is trending as it partners to power Nexo's U.S. crypto market return through its regulated infrastructure, alongside growing speculation it could become core "plumbing" for parent company ICE's new NYSE tokenized trading platform. Community discussion is focused on Bakkt's pivotal role in stablecoin initiatives and its continued correlation with broader cryptocurrency market trends.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending amid heightened M&A speculation in the booming obesity market, fueled by positive Phase 1 data for its differentiated treatment, WVE-007, which offers fat loss with muscle preservation and infrequent dosing. Additionally, the company recently regained full rights to its WVE-006 AATD program, with plans to pursue an accelerated approval pathway, further exciting the community about its RNA-based therapeutic platform.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Down 4.4% - Time to Sell?

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Trading Down 4.4% - What's Next...

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?

EyePoint (EYPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Sees Unusually-High Trading Volume - Time to Buy?

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Sees Large Volume Increase - What's Next...

Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Consensus Rating of "Buy" by Brokerages

Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT - Get Free Report) has been given a consensus rating of "Buy" by the seven brokerages that are covering the company, Marketbeat.com reports. One research...

EyePoint Pharmaceuticals Teases Mid-2026 DURAVYU Wet AMD Data, Starts Phase III DME Program

EyePoint Pharmaceuticals (NASDAQ:EYPT) used a presentation at the Guggenheim Emerging Biotech Emerging Outlook Biotech Summit 2026 to outline upcoming clinical catalysts for its lead retinal program...

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Trading 7.8% Higher - Here's Why

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Stock Price Up 7.8% - What's Next...

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Down 5.3% - Here's What Happened

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Down 5.3% - Should You Sell...

Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Average Recommendation of "Buy" by Brokerages

Shares of Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT - Get Free Report) have earned a consensus rating of "Buy" from the seven brokerages that are currently covering the stock, MarketBeat reports...

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up - Time to Buy?

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Up - What's Next...

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Trading Down 4.6% - Here's Why

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Down 4.6% - What's Next...

EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $WMT earnings on Thursday?

EYPT
EyePoint Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest EYPT News

EYPTEyePoint Pharmaceuticals Inc